These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25843843)

  • 21. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving the Solubility, Stability, and Bioavailability of Albendazole through Synthetic Salts.
    Yan H; Zhong X; Liu Y
    Molecules; 2024 Jul; 29(15):. PubMed ID: 39124976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First solid-state NMR spectroscopy evaluation of complexes of benznidazole with cyclodextrin derivatives.
    Priotti J; Ferreira MJ; Lamas MC; Leonardi D; Salomon CJ; Nunes TG
    Carbohydr Polym; 2015 Oct; 131():90-7. PubMed ID: 26256164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cyclodextrin derivation and amorphous state of complex on accelerated degradation of ziprasidone.
    Hong J; Shah JC; Mcgonagle MD
    J Pharm Sci; 2011 Jul; 100(7):2703-16. PubMed ID: 21283987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
    Fathy M; Sheha M
    Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of inclusion complex of epothilone A with cyclodextrins.
    Xiao CF; Li K; Huang R; He GJ; Zhang JQ; Zhu L; Yang QY; Jiang KM; Jin Y; Lin J
    Carbohydr Polym; 2014 Feb; 102():297-305. PubMed ID: 24507285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
    Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating albendazole desmotropes by solid-state NMR spectroscopy.
    Chattah AK; Zhang R; Mroue KH; Pfund LY; Longhi MR; Ramamoorthy A; Garnero C
    Mol Pharm; 2015 Mar; 12(3):731-41. PubMed ID: 25584993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple complexation of cyclodextrin with soy isoflavones present in an enriched fraction.
    Yatsu FK; Koester LS; Lula I; Passos JJ; Sinisterra R; Bassani VL
    Carbohydr Polym; 2013 Oct; 98(1):726-35. PubMed ID: 23987405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the inclusion processes of styrene and alpha-methyl-styrene in beta-cyclodextrin.
    Cao Y; Xiao X; Ji S; Lu R; Guo Q
    Spectrochim Acta A Mol Biomol Spectrosc; 2004 Mar; 60(4):815-20. PubMed ID: 15036092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.
    Dupuy N; Marquis S; Vanhove G; Bria M; Kister J; Vrielynck L
    Appl Spectrosc; 2004 Jun; 58(6):711-8. PubMed ID: 15198824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between lonidamine and beta- or hydroxypropyl-beta-cyclodextrin.
    Palmieri GF; Wehrlé P; Martelli S
    Drug Dev Ind Pharm; 1998 Jul; 24(7):653-60. PubMed ID: 9876510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization, inclusion mode, phase-solubility and in vitro release studies of inclusion binary complexes with cyclodextrins and meglumine using sulfamerazine as model drug.
    Aloisio C; Gomes de Oliveira A; Longhi M
    Drug Dev Ind Pharm; 2014 Jul; 40(7):919-28. PubMed ID: 23627444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantiotropically related albendazole polymorphs.
    Pranzo MB; Cruickshank D; Coruzzi M; Caira MR; Bettini R
    J Pharm Sci; 2010 Sep; 99(9):3731-42. PubMed ID: 20112428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physicochemical characterization and dissolution properties of nimesulide-cyclodextrin binary systems.
    Nalluri BN; Chowdary KP; Murthy KV; Hayman AR; Becket G
    AAPS PharmSciTech; 2003; 4(1):E2. PubMed ID: 12916912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dissolution/Permeation of Albendazole in the Presence of Cyclodextrin and Bile Salts: A Mechanistic In Vitro Study into Factors Governing Oral Bioavailability.
    Eriksen JB; Christensen SB; Bauer-Brandl A; Brandl M
    J Pharm Sci; 2022 Jun; 111(6):1667-1673. PubMed ID: 34808218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Super Aqueous Solubility of Albendazole in β-Cyclodextrin for Parenteral Application in Cancer therapy.
    Pillai K; Akhter J; Morris DL
    J Cancer; 2017; 8(6):913-923. PubMed ID: 28529602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of bioavailability and anthelmintic efficacy of albendazole by solid dispersion and cyclodextrin complexation techniques.
    Kalaiselvan R; Mohanta GP; Madhusudan S; Manna PK; Manavalan R
    Pharmazie; 2007 Aug; 62(8):604-7. PubMed ID: 17867556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.